Supernus Pharma (SUPN) Tops Q3 EPS by 11c; Lowers FY Revenue Outlook
Go back to Supernus Pharma (SUPN) Tops Q3 EPS by 11c; Lowers FY Revenue Outlook| SUPERNUS PHARM (NASDAQ: SUPN) | Delayed: 45.06 +0.58 (1.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $44.48 | 52 Week High | $26.84 | |||
| Open | $44.69 | 52 Week Low | $9.51 | |||
| Day High | $45.50 | P/E | N/A | |||
| Day Low | $44.44 | EPS | $-2.62 | |||
| Volume | 111,820 | |||||

